Skip to content

The Impacts of the Different Anesthesia Methods on Patients of Transbronchial Cryobiopsy

The Impacts of the Different Anesthesia Methods on Patients of Transbronchial Cryobiopsy:A Prospective, Randomized, Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04099069
Enrollment
60
Registered
2019-09-23
Start date
2019-10-01
Completion date
2020-06-01
Last updated
2019-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Rigid Bronchoscopy, Safety, Tracheal Intubation, Transbronchial Cryobiopsy

Keywords

Transbronchial Cryobiopsy, anesthesia, tracheal intubation, rigid bronchoscopy, safety, interstitial lung disease

Brief summary

to evaluate the difference between the tracheal intubation (TI) and rigid bronchoscopy (RB) under general anesthesia on patients with transbronchial cryobiopsy.

Detailed description

To evaluate the difference between the tracheal intubation (TI) and rigid bronchoscopy (RB) under general anesthesia on patients with transbronchial cryobiopsy. Comparing the difference between two groups in the operating duration, extubation duration, total anesthesia time, heart rate, blood pressure and arterial blood gas analysis. This is a prospective, randomized, controlled trial.

Interventions

PROCEDUREanesthesia

patient was insert trachial intubation or rigid bronchoscopy with ventilation under general anesthesia

Sponsors

Guangzhou Institute of Respiratory Disease
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. The patients are admitted in the institution as ILD, while undefined after thorough history collection, laboratory examination and radiological data. 2. Transbronchial cryobiopsy(TBCB) is indicated by clinicians for definitive diagnosis and patients are content with the examination with agreement signed. 3. Blood gas analysis, routine blood test, ECG examination, coagulation function, immunological examination, chest HRCT, and liver/kidney function test have been completed

Exclusion criteria

1. The radiological data indicates non-ILD 2. The clinical examinations mentioned above are not completed. 3. The patient cannot endure or does not agree the procedure.

Design outcomes

Primary

MeasureTime frameDescription
the fluctuation of heart rate24 hoursfluctuation of heart rate during the procedure
the fluctuation of blood pressure24 hoursthe fluctuation of blood pressure during the procedure
the fluctuation of arterial partial pressure of carbon dioxide24 hoursthe fluctuation of arterial partial pressure of carbon dioxide during the procedure

Countries

China

Contacts

Primary ContactShiyue Li, master
lishiyue@188.com+8613902233925
Backup ContactXiaobo Chen, master
xiaobo-win@163.com+8613751721744

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026